Ishita Drugs & Industries Limited has issued a formal notice to BSE Limited regarding an upcoming board meeting scheduled for Tuesday, 22nd September, 2026. The disclosure is made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The primary agenda for the board meeting includes:
- Consideration and approval of raising funds by the Company through working capital and project term loan facilities
- Approval of terms and conditions for the proposed fundraising
- Any other matter with permission of the chair
The notice was digitally signed by Jagdishprasad Gokulchand Agrawal, Managing Director (DIN: 01031687), on 18.09.2026 at 17:59:06 +05:30. The company's corporate office is located at 401, 3rd Floor, Opp. Parimal Garden, C. G. Road, Ahmedabad-380006, with registered office and factory at 119/1, Visnagar-Vadodara, Tal. Sanand, Dist. Ahmedabad.
No specific financial amounts, interest rates, tenure details, or lender information for the proposed loan facilities were disclosed in this filing. The document serves as formal intimation of the board meeting agenda as required by SEBI listing regulations.